Canandaigua National Corp Medtronic PLC Transaction History

Canandaigua National Corp

$589 Million
Q4 2022

A detailed history of Canandaigua National Corp transactions in Medtronic PLC stock. As of the latest transaction made, Canandaigua National Corp holds 17,374 shares of MDT stock, worth $1.55 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

17,374

Previous 17,526 0.87%

Holding current value

$1.55 Million

Previous $1.42 Million 4.59%

% of portfolio

0.23%

Previous 0.25%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$76.18 - $87.74 $11,579 - $13,336	-152 Reduced 0.87%	17,374 $1.35 Million
Q3 2022 Oct 05, 2022	BUY	$80.75 - $95.31 $123,224 - $145,443	1,526 Added 9.54%	17,526 $1.42 Million
Q2 2022 Jul 05, 2022	SELL	$87.4 - $113.09 $61,267 - $79,276	-701 Reduced 4.2%	16,000 $1.44 Million
Q1 2022 May 09, 2022	SELL	$100.58 - $112.38 $1.15 Million - $1.28 Million	-11,420 Reduced 40.61%	16,701 $1.85 Million
Q4 2021 Jan 04, 2022	SELL	$99.53 - $127.75 $37,423 - $48,034	-376 Reduced 1.32%	28,121 $2.91 Million
Q3 2021 Oct 04, 2021	BUY	$122.75 - $135.17 $32,897 - $36,225	268 Added 0.95%	28,497 $3.57 Million
Q2 2021 Jul 06, 2021	SELL	$118.19 - $131.5 $240,043 - $267,076	-2,031 Reduced 6.71%	28,229 $3.5 Million
Q1 2021 Apr 05, 2021	BUY	$111.18 - $119.74 $28,906 - $31,132	260 Added 0.87%	30,260 $3.58 Million
Q4 2020 Feb 11, 2021	SELL	$100.57 - $117.14 $228,796 - $266,493	-2,275 Reduced 7.05%	30,000 $3.51 Million
Q3 2020 Oct 19, 2020	BUY	$90.13 - $108.78 $152,049 - $183,511	1,687 Added 5.52%	32,275 $3.35 Million
Q2 2020 Jul 07, 2020	BUY	$84.11 - $103.33 $2.57 Million - $3.16 Million	30,588 New	30,588 $2.81 Million

Others Institutions Holding MDT

# of Institutions

2,241

Shares Held

1.04B

Call Options Held

7.1M

Put Options Held

4.39M

View Full List

About Medtronic plc

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $119B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

More about MDT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Canandaigua National Corp, based on Form 13F filings with the SEC.

News

Stay updated on Canandaigua National Corp with notifications on news.

Account

Canandaigua National Corp Medtronic PLC Transaction History